India is expected to be among the top three pharmaceutical markets by incremental growth, by 2020 and sixth largest market globally in absolute size. The medical infrastructure has been continuously improving combined with increase in penetration of health insurance in the country, which are influence factors in the growth of the pharmaceutical sector. To serve this local and export growth market the global drug manufacturing companies have strategically selected india for production. These companies can only rely on global leaders such as Burkert Fluid Control Systems, due to their experience in providing standard and customized components for pharmaceutical production equipment. Sadiq Khan, General Manager, reveals more about Burkert with Pharma Bio World.
What will Burkert offer to the Indian market?
Wherever fluids and gases are used, there is always a need to measure, control and regulate. Burkert has an array of products under major segments like hygiene, water, gas and micro. We help customers right from the conceptual process drawings to select the correct blocks and instrumentation products to reduce the risk of cross contamination and hold-up volume. Our goal is to increase productivity, yield, efficiency, and drug quality.
Our product range extends from sanitary diaphragm valves to instruments such as flow, temperature, level pressure, pH, ORP, dissolved oxygen, chlorine, and turbidity. We work closely with our customers to help in overcoming their fluid challenges by providing best solutions and optimizing processes. We offer products with different options based on the requirements with standard and fluctuating flow conditions. We also deliver product loop solutions to manage flow and de-stress immediate following processes. Apart from regular product-based solutions, we also build innovative application-oriented system solutions for complex processes to deliver maximum customer benefit. Whether it is a single component or a pioneering new system for a complete monitoring and regulation project, we offer an extensive range of services, from consultancy and the engineering of products or complex systems to installation, testing and after-sales service.
How is Burkert technologically different from the current market products?
This story is from the July 2018 edition of Pharma Bio World.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the July 2018 edition of Pharma Bio World.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
B&R Expands Gilgenberg Site
Automation specialist invests in production, office space and logisticsB&R is investing in its Gilgenberg site, located a few kilometers from the B&R headquarters in Eggelsberg. The expansion adds new offices, training rooms and production space. A new logistics hall has also been opened at the site.
Creating An Annual Event Of The Biopharma Industry By Focusing On Frontiers, & Promoting Leading Enterprises To Collaborate
The Union Budget 2018 was presented on February 1, 2018.
Pain Point To Gaining Brownie Points: Technology Is A Game Changer For Indian Pharma Sector
The Indian pharmaceutical industry has come a long way from traditional home-made herbal medicines to being the manufacturer of world class life-saving drugs. However, at the helm of game-changing innovations steering this industry to a whole new level is the implementation of technology.
Data Acquisition, Evaluation And Transmission To The Cloud
A single device to acquire data, evaluate it and send it to the cloud – that’s now possible with B&R’s Edge Controller. The powerful industrial PC can even be used for big data analysis and machine learning, while at the same time serving as a full-fledged industrial controller.
Just The Right Dose Of Intelligence
Nothing herein shall constitute an offer to sell, or a solicitation of an offer to buy. The ACOPO Strak product is not available for sale into the United States of America until September 2018.
Considerations For Extraction, Stabilization And Quantification By PCR For Sensitive Sample Such As RNA
This article talks about careful selection of an extraction system that helps stabilize and protect targets, especially RNA, or which allows for immediate analysis.
Novel Research In Pharmaceuticals And Bio-Pharmaceuticals
This article covers entire spectra of pharmaceutical research and as well as those related to synthesis and processing of pharmaceuticals.
Boost Productivity With Anti-sloshing
Transport liquids faster without spills With B&R’s industrial transport system, it is now possible to transport liquids quickly with no spills. SuperTrak is the only system on the market to offer anti-sloshing technology. This technology suppresses the format ion of oscillations on free surfaces to prevent liquids from spilling over container edges during transport .
Rational Use Of Drugs And Irrational Drug Combinations
Irrational use of medicines is a global phenomenon. Rational use of drugs may be defined as: Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and the lowest cost to them and their community. Overuse, polypharmacy and incorrect use of drugs are the most common problems of drug use today. Irrational use of drugs may result due to various reasons at various levels including the prescribing errors and over the counter drugs. Irrational use of medicines may lead to serious negative health and economic consequences. Many irrational drug combinations are available in the Indian market. Proper implementation of rational use of drugs will improve the quality of life and result in better community healthcare.
Cold Chain Management For Sensitive Goods
Packaging, route planning and risk analysis ensure safe conditions during transportation of delicate drugs. Drugs are sensitive goods to transport, which can be subject to irreversible damage if they are stored or transported at temperatures outside the tolerated range. If the temperature falls below or rises above the specified range the quality of drugs requiring refrigeration can be seriously affected and they may cease to be effective. This article therefore describes how transport conditions during the transportation of drugs can be optimised through suitable packaging, individualised process design, the analysis and assessment of potential risks and close collaboration between the sender and the freight carrier.
